The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
Neuroblastoma—A Neural Crest Derived Embryonal Malignancy
Open accessAbstract
Neuroblastoma is a neural crest derived malignancy of the peripheral nervous system and is the most common and deadliest tumor of infancy. It is characterized by clinical heterogeneity with a disease spectrum ranging from spontaneous regression without any medical intervention to treatment resistant tumors with metastatic spread and poor patient survival. The events that lead to the development of neuroblastoma from the neural crest have not been fully elucidated. Here we discuss factors and processes within the neural crest that when dysregulated have the potential to be initiators or drivers of neuroblastoma development. A more precise biological understanding of neuroblastoma causes and cell of origin is highly warranted. This will give valuable information for the development of medicines that specifically target molecules within neuroblastoma cells and also give hint about the mechanisms behind treatment resistance that is frequently seen in neuroblastoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310 · cited 1×
“Lin28B has also been shown to be important for the maintenance of stemness during embryonic development (Yu et al., 2007).”
BackgroundNeuroblastoma: biological insights into a clinical enigma
Brodeur, G. M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1014 · Cited by 2,160
Recent Advances in Neuroblastoma
Maris, J. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0804577 · Cited by 1,983
ROCKs: multifunctional kinases in cell behaviour
Riento, K., & Ridley, A. J. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1128 · Cited by 1,941
WNT signalling pathways as therapeutic targets in cancer
Anastas, J. N., & Moon, R. T. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3419 · Cited by 1,911
Apoptosis in the nervous system
Yuan, J., & Yankner, B. A. (2000) · Nature · doi:10.1038/35037739 · Cited by 1,877
Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma
Yu, A. L., Gilman, A. L., Ozkaynak, M. F., London, W. B., Kreissman, S. G., Chen, H. X., Smith, M., Anderson, B., Villablanca, J. G., Matthay, K. K., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0911123 · Cited by 1,835 · cited 2×
“Anti-GD2 antibodies have for the last 20 years been successfully applied as a treatment option for high-risk neuroblastoma and recent studies have shown further increased survival of patients with high-risk neuroblastoma treated with a combination of chimeric anti-GD2 antibodies, GM-CSF and IL-2 suggesting more system…”
BackgroundMethodSelective Blockade of MicroRNA Processing by Lin28
Viswanathan, S. R., Daley, G. Q., & Gregory, R. I. (2008) · Science · doi:10.1126/science.1154040 · Cited by 1,437
Matthay, K. K., Maris, J. M., Schleiermacher, G., Nakagawara, A., Mackall, C. L., Diller, L., & Weiss, W. A. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.78 · Cited by 1,419
Identification of ALK as a major familial neuroblastoma predisposition gene
Mossé, Y. P., Laudenslager, M., Longo, L., Cole, K. A., Wood, A., Attiyeh, E. F., Laquaglia, M. J., Sennett, R., Lynch, J. E., Perri, P., et al. (2008) · Nature · doi:10.1038/nature07261 · Cited by 1,407 · cited 2×
“ALK mutations are also present in almost all cases of familial neuroblastomas which account for 1%–2% of the neuroblastoma cases (Mossé et al., 2008).”
BackgroundExome sequencing identifies recurrent somatic RAC1 mutations in melanoma
Krauthammer, M., Kong, Y., Ha, B. H., Evans, P., Bacchiocchi, A., McCusker, J. P., Cheng, E., Davis, M. J., Goh, G., Choi, M., et al. (2012) · Nature Genetics · doi:10.1038/ng.2359 · Cited by 1,191
The genetic landscape of high-risk neuroblastoma
Pugh, T. J., Morozova, O., Attiyeh, E. F., Asgharzadeh, S., Wei, J. S., Auclair, D., Carter, S. L., Cibulskis, K., Hanna, M., Kiezun, A., et al. (2013) · Nature Genetics · doi:10.1038/ng.2529 · Cited by 1,186
The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report
Monclair, T., Brodeur, G. M., Ambros, P. F., Brisse, H. J., Cecchetto, G., Holmes, K., Kaneko, M., London, W. B., Matthay, K. K., Nuchtern, J. G., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.6876 · Cited by 1,150
A proposed staging for children with neuroblastoma.Children's cancer study group A
Evans, A. E., D'Angio, G. J., & Randolph, J. (1971) · Cancer · doi:10.1002/1097-0142(197102)27:2<374::aid-cncr2820270221>3.0.co;2-g · Cited by 950
The homeobox gene Phox2b is essential for the development of autonomic neural crest derivatives
Pattyn, A., Morin, X., Cremer, H., Goridis, C., & Brunet, J.-F. (1999) · Nature · doi:10.1038/20700 · Cited by 875
Targeted expression of MYCN causes neuroblastoma in transgenic mice
Weiss, W. A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.11.2985 · Cited by 870
Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes
Molenaar, J. J., Koster, J., Zwijnenburg, D. A., van Sluis, P., Valentijn, L. J., van der Ploeg, I., Hamdi, M., van Nes, J., Westerman, B. A., van Arkel, J., et al. (2012) · Nature · doi:10.1038/nature10910 · Cited by 870
Matthay, K. K., Reynolds, C. P., Seeger, R. C., Shimada, H., Adkins, E. S., Haas-Kogan, D., Gerbing, R. B., London, W. B., & Villablanca, J. G. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.8925 · Cited by 858
Neuroblastoma: developmental biology, cancer genomics and immunotherapy
Cheung, N.-K. V., & Dyer, M. A. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3526 · Cited by 801
Rybak, A., Fuchs, H., Smirnova, L., Brandt, C., Pohl, E. E., Nitsch, R., & Wulczyn, F. G. (2008) · Nature Cell Biology · doi:10.1038/ncb1759 · Cited by 787
Alternative Neural Crest Cell Fates Are Instructively Promoted by TGFβ Superfamily Members
Shah, N. M., Groves, A. K., & Anderson, D. J. (1996) · Cell · doi:10.1016/s0092-8674(00)81112-5 · Cited by 782
A BDNF autocrine loop in adult sensory neurons prevents cell death
Acheson, A., Conover, J. C., Fandl, J. P., DeChiara, T. M., Russell, M., Thadani, A., Squinto, S. P., Yancopoulos, G. D., & Lindsay, R. M. (1995) · Nature · doi:10.1038/374450a0 · Cited by 765
Melanoma genome sequencing reveals frequent PREX2 mutations
Berger, M. F., Hodis, E., Heffernan, T. P., Deribe, Y. L., Lawrence, M. S., Protopopov, A., Ivanova, E., Watson, I. R., Nickerson, E., Ghosh, P., et al. (2012) · Nature · doi:10.1038/nature11071 · Cited by 756
Iwahara, T., Fujimoto, J., Wen, D., Cupples, R., Bucay, N., Arakawa, T., Mori, S., Ratzkin, B., & Yamamoto, T. (1997) · Oncogene · doi:10.1038/sj.onc.1200849 · Cited by 726
Nakagawara, A., Arima-Nakagawara, M., Scavarda, N. J., Azar, C. G., Cantor, A. B., & Brodeur, G. M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199303253281205 · Cited by 694
Lin-28 interaction with the Let-7 precursor loop mediates regulated microRNA processing
Newman, M. A., Thomson, J. M., & Hammond, S. M. (2008) · RNA · doi:10.1261/rna.1155108 · Cited by 692
Neuroblastoma: Biology, Prognosis, and Treatment
Park, J. R., Eggert, A., & Caron, H. (2010) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2009.11.011 · Cited by 620
Lin28A and Lin28B Inhibit let-7 MicroRNA Biogenesis by Distinct Mechanisms
Piskounova, E., Polytarchou, C., Thornton, J. E., LaPierre, R. J., Pothoulakis, C., Hagan, J. P., Iliopoulos, D., & Gregory, R. I. (2011) · Cell · doi:10.1016/j.cell.2011.10.039 · Cited by 612
Telomerase activation by genomic rearrangements in high-risk neuroblastoma
Peifer, M., Hertwig, F., Roels, F., Dreidax, D., Gartlgruber, M., Menon, R., Krämer, A., Roncaioli, J. L., Sand, F., Heuckmann, J. M., et al. (2015) · Nature · doi:10.1038/nature14980 · Cited by 595
London, W. B., Castleberry, R. P., Matthay, K. K., Look, A. T., Seeger, R. C., Shimada, H., Thorner, P., Brodeur, G., Maris, J. M., Reynolds, C. P., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.571 · Cited by 589
Signal Transduction in Neuronal Migration
Wong, K., Ren, X.-R., Huang, Y.-Z., Xie, Y., Liu, G., Saito, H., Tang, H., Wen, L., Brady-Kalnay, S. M., Mei, L., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00530-x · Cited by 550
Differential expression of myc family genes during murine development
Zimmerman, K. A., Yancopoulos, G. D., Collum, R. G., Smith, R. K., Kohl, N. E., Denis, K. A., Nau, M. M., Witte, O. N., Toran-Allerand, D., Gee, C. E., et al. (1986) · Nature · doi:10.1038/319780a0 · Cited by 540
Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations
Eleveld, T. F., Oldridge, D. A., Bernard, V., Koster, J., Daage, L. C., Diskin, S. J., Schild, L., Bentahar, N. B., Bellini, A., Chicard, M., et al. (2015) · Nature Genetics · doi:10.1038/ng.3333 · Cited by 540
Association of Age at Diagnosis and Genetic Mutations in Patients With Neuroblastoma
Cheung, N.-K. V. (2012) · JAMA · doi:10.1001/jama.2012.228 · Cited by 468
Neuroblastoma Screening at One Year of Age
Schilling, F. H., Spix, C., Berthold, F., Erttmann, R., Fehse, N., Hero, B., Klein, G., Sander, J., Schwarz, K., Treuner, J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012277 · Cited by 464
Expression and function of TRK-B and BDNF in human neuroblastomas.
Nakagawara, A., Azar, C. G., Scavarda, N. J., & Brodeur, G. M. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.1.759 · Cited by 423
Anaplastic lymphoma kinase: signalling in development and disease
Palmer, R. H., Vernersson, E., Grabbe, C., & Hallberg, B. (2009) · Biochemical Journal · doi:10.1042/bj20090387 · Cited by 423
Sausen, M., Leary, R. J., Jones, S., Wu, J., Reynolds, C. P., Liu, X., Blackford, A., Parmigiani, G., Diaz, L. A., Papadopoulos, N., et al. (2013) · Nature Genetics · doi:10.1038/ng.2493 · Cited by 414
Ambros, P. F., Ambros, I. M., Brodeur, G. M., Haber, M., Khan, J., Nakagawara, A., Schleiermacher, G., Speleman, F., Spitz, R., London, W. B., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605014 · Cited by 404
IN SITU NEUROBLASTOMAS: A CONTRIBUTION TO THE NATURAL HISTORY OF NEURAL CREST TUMORS.
Jb, B., & Perrin, E. V. (1963) · PubMed · Cited by 403
SPECIAL PATTERN OF WIDESPREAD NEUROBLASTOMA WITH A FAVOURABLE PROGNOSIS
D'Angio, G., Evans, A., & Koop, C. E. (1971) · The Lancet · doi:10.1016/s0140-6736(71)91606-0 · Cited by 401
TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors
Valentijn, L. J., Koster, J., Zwijnenburg, D. A., Hasselt, N. E., van Sluis, P., Volckmann, R., van Noesel, M. M., George, R. E., Tytgat, G. A. M., Molenaar, J. J., et al. (2015) · Nature Genetics · doi:10.1038/ng.3438 · Cited by 396
Overview and recent advances in the treatment of neuroblastoma
Whittle, S. B., Smith, V., Doherty, E., Zhao, S., McCarty, S., & Zage, P. E. (2017) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2017.1285230 · Cited by 394
Irwin, M. S., & Park, J. R. (2015) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2014.09.015 · Cited by 392
Bresler, S. C., Weiser, D. A., Huwe, P. J., Park, J. H., Krytska, K., Ryles, H., Laudenslager, M., Rappaport, E. F., Wood, A. C., McGrady, P. W., et al. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.09.019 · Cited by 388
The role of the ALK receptor in cancer biology
Hallberg, B., & Palmer, R. H. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw301 · Cited by 377
Activated ALK Collaborates with MYCN in Neuroblastoma Pathogenesis
Zhu, S., Lee, J.-S., Guo, F., Shin, J., Perez-Atayde, A. R., Kutok, J. L., Rodig, S. J., Neuberg, D. S., Helman, D., Feng, H., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.010 · Cited by 365
Reissmann, E., Ernsberger, U., Francis-West, P. H., Rueger, D., Brickell, P. M., & Rohrer, H. (1996) · Development · doi:10.1242/dev.122.7.2079 · Cited by 361
Copy number variation at 1q21.1 associated with neuroblastoma
Diskin, S. J., Hou, C., Glessner, J. T., Attiyeh, E. F., Laudenslager, M., Bosse, K., Cole, K., Mossé, Y. P., Wood, A., Lynch, J. E., et al. (2009) · Nature · doi:10.1038/nature08035 · Cited by 354
Ladenstein, R., Pötschger, U., Pearson, A. D. J., Brock, P., Luksch, R., Castel, V., Yaniv, I., Papadakis, V., Laureys, G., Malis, J., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30070-0 · Cited by 350
Pandey, G. K., Mitra, S., Subhash, S., Hertwig, F., Kanduri, M., Mishra, K., Fransson, S., Ganeshram, A., Mondal, T., Bandaru, S., et al. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.09.014 · Cited by 343
Blockus, H., & Chédotal, A. (2016) · Development · doi:10.1242/dev.132829 · Cited by 343
The ALKF1174L Mutation Potentiates the Oncogenic Activity of MYCN in Neuroblastoma
Berry, T., Luther, W., Bhatnagar, N., Jamin, Y., Poon, E., Sanda, T., Pei, D., Sharma, B., Vetharoy, W. R., Hallsworth, A., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.06.001 · Cited by 326
Chromosome 6p22 Locus Associated with Clinically Aggressive Neuroblastoma
Maris, J. M., Mosse, Y. P., Bradfield, J. P., Hou, C., Monni, S., Scott, R. H., Asgharzadeh, S., Attiyeh, E. F., Diskin, S. J., Laudenslager, M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708698 · Cited by 319
Integrative genomics identifies LMO1 as a neuroblastoma oncogene
Wang, K., Diskin, S. J., Zhang, H., Attiyeh, E. F., Winter, C., Hou, C., Schnepp, R. W., Diamond, M., Bosse, K., Mayes, P. A., et al. (2011) · Nature · doi:10.1038/nature09609 · Cited by 310
Trk Receptor Expression and Inhibition in Neuroblastomas
Brodeur, G. M., Minturn, J. E., Ho, R., Simpson, A. M., Iyer, R., Varela, C. R., Light, J. E., Kolla, V., & Evans, A. E. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1815 · Cited by 307
Common variations in BARD1 influence susceptibility to high-risk neuroblastoma
Capasso, M., Devoto, M., Hou, C., Asgharzadeh, S., Glessner, J. T., Attiyeh, E. F., Mosse, Y. P., Kim, C., Diskin, S. J., Cole, K. A., et al. (2009) · Nature Genetics · doi:10.1038/ng.374 · Cited by 305
Mutational dynamics between primary and relapse neuroblastomas
Schramm, A., Köster, J., Assenov, Y., Althoff, K., Peifer, M., Mahlow, E., Odersky, A., Beisser, D., Ernst, C., Henssen, A. G., et al. (2015) · Nature Genetics · doi:10.1038/ng.3349 · Cited by 304
Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism
Oldridge, D. A., Wood, A. C., Weichert-Leahey, N., Crimmins, I., Sussman, R., Winter, C., McDaniel, L. D., Diamond, M., Hart, L. S., Zhu, S., et al. (2015) · Nature · doi:10.1038/nature15540 · Cited by 301
Mechanisms of neuroblastoma regression
Brodeur, G. M., & Bagatell, R. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.168 · Cited by 284
The prenatal origins of cancer
Marshall, G. M., Carter, D. R., Cheung, B. B., Liu, T., Mateos, M. K., Meyerowitz, J. G., & Weiss, W. A. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3679 · Cited by 281
Mody, R., Naranjo, A., Van Ryn, C., Yu, A. L., London, W. B., Shulkin, B. L., Parisi, M. T., Servaes, S.-E.-N., Diccianni, M. B., Sondel, P. M., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30355-8 · Cited by 277
Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma
Diskin, S. J., Capasso, M., Schnepp, R. W., Cole, K. A., Attiyeh, E. F., Hou, C., Diamond, M., Carpenter, E. L., Winter, C., Lee, H., et al. (2012) · Nature Genetics · doi:10.1038/ng.2387 · Cited by 266
Kogner, P., Barbany, G., Dominici, C., Castello, M. A., Raschellà, G., & Persson, H. (1993) · PubMed · Cited by 247
The Expanding World of N-MYC–Driven Tumors
Rickman, D. S., Schulte, J. H., & Eilers, M. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0273 · Cited by 241
On Trk—The TrkB Signal Transduction Pathway Is an Increasingly Important Target in Cancer Biology
Thiele, C. J., Li, Z., & McKee, A. E. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0651 · Cited by 238
Spontaneous regression of neuroblastoma
Brodeur, G. M. (2018) · Cell and Tissue Research · doi:10.1007/s00441-017-2761-2 · Cited by 235
Carén, H., Kryh, H., Nethander, M., Sjöberg, R.-M., Träger, C., Nilsson, S., Abrahamsson, J., Kogner, P., & Martinsson, T. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910684107 · Cited by 232
Tang, L., Nogales, E., & Ciferri, C. (2010) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2010.05.001 · Cited by 232
A population-based study of the usefulness of screening for neuroblastoma
Woods, W. G., Tuchman, M., Robison, L. L., Bernstein, M., Leclerc, J.-M., Brisson, L. C., Brossard, J., Hill, G., Shuster, J., Luepker, R., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)06020-5 · Cited by 231
Essential role of Gata transcription factors in sympathetic neuron development
Tsarovina, K., Pattyn, A., Stubbusch, J., Müller, F., van der Wees, J., Schneider, C., Brunet, J.-F., & Rohrer, H. (2004) · Development · doi:10.1242/dev.01370 · Cited by 226
Bosse, K. R., & Maris, J. M. (2016) · Cancer · doi:10.1002/cncr.29706 · Cited by 220
Emergence of New ALK Mutations at Relapse of Neuroblastoma
Schleiermacher, G., Javanmardi, N., Bernard, V., Leroy, Q., Cappo, J., Rio Frio, T., Pierron, G., Lapouble, E., Combaret, V., Speleman, F., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.0674 · Cited by 215
A Systematic Review of Molecular and Biological Tumor Markers in Neuroblastoma
Riley, R. D., Heney, D., Jones, D. R., Sutton, A. J., Lambert, P. C., Abrams, K. R., Young, B., Wailoo, A. J., & Burchill, S. A. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1051-2 · Cited by 203
Matsumoto, K., Wada, R. K., Yamashiro, J. M., Kaplan, D., & Cj, T. (1995) · PubMed · Cited by 193
Targeted Expression of Mutated ALK Induces Neuroblastoma in Transgenic Mice
Heukamp, L. C., Thor, T., Schramm, A., De Preter, K., Kumps, C., De Wilde, B., Odersky, A., Peifer, M., Lindner, S., Spruessel, A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003967 · Cited by 181
Characterization of the expression of the ALK receptor tyrosine kinase in mice
Vernersson, E., Khoo, N. K. S., Henriksson, M. L., Roos, G., Palmer, R. H., & Hallberg, B. (2006) · Gene Expression Patterns · doi:10.1016/j.modgep.2005.11.006 · Cited by 178
Two related ARID family proteins are alternative subunits of human SWI/SNF complexes
WANG, X., NAGL, N. G., WILSKER, D., VAN SCOY, M., PACCHIONE, S., YACIUK, P., DALLAS, P. B., & MORAN, E. (2004) · Biochemical Journal · doi:10.1042/bj20040524 · Cited by 177
Expression of TrkA, TrkB and TrkC in human neuroblastomas
Brodeur, G. M., Nakagawara, A., Yamashiro, D. J., Ikegaki, N., Liu, X.-G., Azar, C. G., Lee, C. P., & Evans, A. E. (1997) · Journal of Neuro-Oncology · doi:10.1023/a:1005729329526 · Cited by 172
The transcription factor dHAND is a downstream effector of BMPs in sympathetic neuron specification
Howard, M. J., Stanke, M., Schneider, C., Wu, X., & Rohrer, H. (2000) · Development · doi:10.1242/dev.127.18.4073 · Cited by 170
CASC15-S Is a Tumor Suppressor lncRNA at the 6p22 Neuroblastoma Susceptibility Locus
Russell, M. R., Penikis, A., Oldridge, D. A., Alvarez-Dominguez, J. R., McDaniel, L., Diamond, M., Padovan, O., Raman, P., Li, Y., Wei, J. S., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3613 · Cited by 169
Kosho, T., Okamoto, N., & Collaborators, C. S. I. (2014) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31407 · Cited by 168
Rare Copy Number Variations in Adults with Tetralogy of Fallot Implicate Novel Risk Gene Pathways
Silversides, C. K., Lionel, A. C., Costain, G., Merico, D., Migita, O., Liu, B., Yuen, T., Rickaby, J., Thiruvahindrapuram, B., Marshall, C. R., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002843 · Cited by 168
A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies
Althoff, K., Beckers, A., Bell, E., Nortmeyer, M., Thor, T., Sprüssel, A., Lindner, S., Preter, K. D., Florin, A., Heukamp, L. C., et al. (2014) · Oncogene · doi:10.1038/onc.2014.269 · Cited by 167
Mechanisms of embryonal tumor initiation: Distinct roles for MycN expression and MYCN amplification
Hansford, L. M., Thomas, W. D., Keating, J. M., Burkhart, C. A., Peaston, A. E., Norris, M. D., Haber, M., Armati, P. J., Weiss, W. A., & Marshall, G. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401083101 · Cited by 159
Mammalian SWI/SNF complexes in cancer: emerging therapeutic opportunities
St. Pierre, R., & Kadoch, C. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2017.02.004 · Cited by 159
Goldstein, A. M., Brewer, K. C., Doyle, A. M., Nagy, N., & Roberts, D. J. (2005) · Mechanisms of Development · doi:10.1016/j.mod.2005.03.003 · Cited by 158
Rho-kinase inhibitors as therapeutics: from pan inhibition to isoform selectivity
Hahmann, C., & Schroeter, T. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0189-x · Cited by 153
Mondal, T., Juvvuna, P. K., Kirkeby, A., Mitra, S., Kosalai, S. T., Traxler, L., Hertwig, F., Wernig-Zorc, S., MIRANDA, C. A., Deland, L., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.01.020 · Cited by 140
Varley, J. E., & Maxwell, G. D. (1996) · Experimental Neurology · doi:10.1006/exnr.1996.0118 · Cited by 131
Neuroblastoma treatment in the post-genomic era
Esposito, M. R., Aveic, S., Seydel, A., & Tonini, G. P. (2017) · Journal of Biomedical Science · doi:10.1186/s12929-017-0319-y · Cited by 124
Mutationally activated Rho GTPases in cancer
Alan, J. K., & Lundquist, E. A. (2013) · Small GTPases · doi:10.4161/sgtp.26530 · Cited by 121
L’Abbate, A., Macchia, G., D’Addabbo, P., Lonoce, A., Tolomeo, D., Trombetta, D., Kok, K., Bartenhagen, C., Whelan, C. W., Palumbo, O., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku590 · Cited by 119
Capasso, M., Diskin, S. J., Totaro, F., Longo, L., Mariano, M. D., Russo, R., Cimmino, F., Hakonarson, H. H., Tonini, G. P., Devoto, M., et al. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs380 · Cited by 115
A LIN28B-RAN-AURKA Signaling Network Promotes Neuroblastoma Tumorigenesis
Schnepp, R. W., Khurana, P., Attiyeh, E. F., Raman, P., Chodosh, S., Oldridge, D. A., Gagliardi, M. E., Conkrite, K. L., Asgharzadeh, S., Seeger, R. C., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.09.012 · Cited by 115
Varley, J. E., Wehby, R. G., Rueger, D. C., & Maxwell, G. D. (1995) · Developmental Dynamics · doi:10.1002/aja.1002030406 · Cited by 109
Cazes, A., Lopez‐Delisle, L., Tsarovina, K., Pierre‐Eugène, C., Preter, K. D., Peuchmaur, M. M., Nicolas, A., Provost, C., Louis‐Brennetot, C., Daveau, R., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.1883 · Cited by 108
Bosse, K. R., Diskin, S. J., Cole, K. A., Wood, A., Schnepp, R. W., Norris, G. T., Nguyễn, L. B., Jagannathan, J., LaQuaglia, M. P., Winter, C. L., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3703 · Cited by 106
MYCN induces neuroblastoma in primary neural crest cells
Olsen, R. R., Otero, J. H., García-López, J., Wallace, K., Finkelstein, D., Rehg, J. E., Yin, Z., Wang, Y.-D., & Freeman, K. W. (2017) · Oncogene · doi:10.1038/onc.2017.128 · Cited by 102
Transcriptional control of differentiation and neurogenesis in autonomic ganglia
Rohrer, H. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07860.x · Cited by 99
Midkine and Alk signaling in sympathetic neuron proliferation and neuroblastoma predisposition
Reiff, T., Huber, L., Krämer, M., Delattre, O., Janoueix‐Lerosey, I., & Rohrer, H. (2011) · Development · doi:10.1242/dev.072157 · Cited by 96
Too many targets, not enough patients: rethinking neuroblastoma clinical trials
Fletcher, J. I., Ziegler, D. S., Trahair, T. N., Marshall, G. M., Haber, M., & Norris, M. D. (2018) · Nature reviews. Cancer · doi:10.1038/s41568-018-0003-x · Cited by 90
Common Genetic Variants in NEFL Influence Gene Expression and Neuroblastoma Risk
Capasso, M., Diskin, S. J., Cimmino, F., Acierno, G., Totaro, F., Petrosino, G., Pezone, L., Diamond, M. A., McDaniel, L., Hakonarson, H. H., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0431 · Cited by 89
Molecular mechanisms and therapeutic targets in neuroblastoma
Johnsen, J. I., Dyberg, C. H., Fransson, S. M., & Wickström, M. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.02.023 · Cited by 84
Self-citationCh14.18 antibody produced in CHO cells in relapsed or refractory Stage 4 neuroblastoma patients
Ladenstein, R. L., Weixler, S., Baykan, B., Bleeke, M., Kunert, R., Katinger, D., Pribill, I., Glander, P., Bauer, S., Pistoia, V., et al. (2013) · mAbs · doi:10.4161/mabs.25215 · Cited by 83
N-myc Promotes Survival and Induces S-Phase Entry of Postmitotic Sympathetic Neurons
Wartiovaara, K., Barnabé‐Heider, F., Miller, F. D., & Kaplan, D. R. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-03-00815.2002 · Cited by 74
Rho-associated kinase is a therapeutic target in neuroblastoma
Dyberg, C. H., Fransson, S. M., Andonova, T., Sveinbjørnsson, B., Lännerholm-Palm, J., Olsen, T. K., Forsberg, D., Herlenius, E., Martinsson, T., Brodin, B. A., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1706011114 · Cited by 71
Self-citationHurley, S. P., Clary, D. O., Copié, V., & Lefcort, F. B. (2006) · The Journal of Comparative Neurology · doi:10.1002/cne.20887 · Cited by 70
Embryonal neural tumours and cell death
Johnsen, J. I., Kogner, P., Albihn, A., & Arsenian‐Henriksson, M. (2009) · APOPTOSIS · doi:10.1007/s10495-009-0325-y · Cited by 70
Self-citationOhmi, Y., Ohkawa, Y., Yamauchi, Y., Tajima, O., Furukawa, K., & Furukawa, K. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0764-7 · Cited by 70
Reiff, T., Tsarovina, K., Majdazari, A., Schmidt, M., del Pino, I., & Rohrer, H. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.5368-09.2010 · Cited by 67
Huang, P., Kishida, S., Cao, D., Murakami‐Tonami, Y., Mu, P., Nakaguro, M., Koide, N., Takeuchi, I., Ōnishi, A., & Kadomatsu, K. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3524 · Cited by 62
Insight into planar cell polarity
Sebbagh, M., & Borg, J. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.09.005 · Cited by 61
Advances in emerging drugs for the treatment of neuroblastoma
Berlanga, P., Cañete, A., & Castel, V. (2017) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2017.1294159 · Cited by 60
Braekeveldt, N., von Stedingk, K., Fransson, S. M., Martinez‐Monleon, A., Lindgren, D., Axelson, H., Levander, F., Willforss, J., Hansson, K., Øra, I., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0527 · Cited by 60
Cimmino, F., Avitabile, M., Diskin, S. J., Vaksman, Z., Pignataro, P., Formicola, D., Cardinale, A., Testori, A., Köster, J., de Torres, C., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31822 · Cited by 54
Valteau‐Couanet, D., Deley, M. L., Bergeron, C., Ducassou, S., Michon, J. M., Rubie, H., Teuff, G. L., Coze, C., Plantaz, D., Sirvent, N., et al. (2013) · Pediatric Blood & Cancer · doi:10.1002/pbc.24713 · Cited by 51
Dualistic Role of BARD1 in Cancer
Cimmino, F., Formicola, D., & Capasso, M. (2017) · Genes · doi:10.3390/genes8120375 · Cited by 51
The SWI/SNF BAF-A complex is essential for neural crest development
Chandler, R. L., & Magnuson, T. (2016) · Developmental Biology · doi:10.1016/j.ydbio.2016.01.015 · Cited by 49
Moreno, L., Caron, H. N., Geoerger, B., Eggert, A., Schleiermacher, G., Brock, P. R., Valteau‐Couanet, D., Chesler, L., Schulte, J. H., Preter, K. D., et al. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1340269 · Cited by 41
Self-citationWislet‐Gendebien, S., Vandervelden, G., & Rogister, B. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00244 · Cited by 37
Boundary formation in the development of the vertebrate hindbrain
Xu, Q., & Wilkinson, D. G. (2013) · Wiley Interdisciplinary Reviews Developmental Biology · doi:10.1002/wdev.106 · Cited by 18
Suppression of Cpn10 Increases Mitochondrial Fission and Dysfunction in Neuroblastoma Cells
Park, S. J., Jo, D. S., Shin, J. H., Kim, E. S., Jo, Y. K., Choi, E. S., Seo, H. M., Kim, S. H., Hwang, J. J., Jo, D., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112130 · Cited by 6
Cited by
Molecular targeting therapies for neuroblastoma: Progress and challenges
Zafar, A., Wang, W., Liu, G., Wang, X., Xian, W., McKeon, F., Foster, J., Zhou, J., & Zhang, R. (2021) · Medicinal Research Reviews · doi:10.1002/med.21750 · Cited by 380
Melanoma, Melanin, and Melanogenesis: The Yin and Yang Relationship
Slominski, R. M., Sarna, T., Płonka, P. M., Raman, C., Brożyna, A. A., & Slominski, A. T. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.842496 · Cited by 286
Diener, J., & Sommer, L. (2021) · Stem Cells Translational Medicine · doi:10.1002/sctm.20-0351 · Cited by 64
Metadata
- Authors
- Johnsen, J. I., Dyberg, C., & Wickström, M.
- Venue
- Frontiers in Molecular Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2019-01-29
- Volume
- 12
- Pages
- 9-9
- ISSN
- 1662-5099 (ISSN-L)
- OpenAlex
- W2915052615
- Cited by
- 277
- References
- 123
- FWCI
- 17.86
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.